Developing p21-activated kinase 1 (PAK1) activators to treat hypertrophic cardiomyopathy (HCM)

Authors: Y He, J Bae, Y J Wang, H Watkins, M Lei

Published: 2024-10-28

DOI: 10.1093/eurheartj/ehae666.3282

Source: Full article


Abstract

Abstract